Published in Am J Med on January 21, 1985
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease. Ann Rheum Dis (1987) 0.80
Study of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate. Ann Rheum Dis (1997) 0.80
Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents. Clin Rheumatol (1997) 0.76
Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc Natl Acad Sci U S A (1983) 2.92
Anomalous sweat chloride levels in cystic fibrosis during antibiotic therapy. Arch Dis Child (1972) 1.99
Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum (1977) 1.58
Cirrhosis associated with methotrexate treatment of psoriasis. JAMA (1968) 1.50
Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator. Arthritis Rheum (1979) 1.30
Abnormalities of connective tissue cells cultured from patients with rheumatoid arthritis. I. Relative unresponsiveness of rheumatoid synovial cells to hydrocortisone. J Lab Clin Med (1966) 1.28
Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor. Arthritis Rheum (1977) 1.15
Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery (1981) 1.15
Hyaluronic acid in human synovial effusions; a sensitive indicator of altered connective tissue cell function during inflammation. Arthritis Rheum (1966) 1.14
Azathioprine-induced acute pancreatitis. N Engl J Med (1973) 1.13
Connective tissue activation. II. Abnormalities of cultured rheumatoid synovial cells. Arthritis Rheum (1971) 1.11
Ultrastructural comparison of rheumatoid and nonrheumatoid synovial fibroblasts grown in tissue culture. Arthritis Rheum (1972) 1.09
Therapeutic value of graded aerobic exercise training in rheumatoid arthritis. Arthritis Rheum (1985) 1.08
Synovial cell activation induced by a polypeptide mediator. Ann N Y Acad Sci (1975) 1.07
Connective tissue activation. XVIII. Stimulation of hyaluronic acid synthetase activity. J Lab Clin Med (1980) 1.06
Effects of rheumatoid sera on fibroblast proliferation and hyaluronic acid synthesis. Arthritis Rheum (1968) 1.06
Measurement of exercise tolerance in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1985) 1.06
Abnormalities of connective tissue cells cultured from patients with rheumatoid arthritis. II. Defective regulation of hyaluronate and collagen formation. J Lab Clin Med (1971) 1.05
Regulation of collagen and hyaluronate formation in human synovial fibroblast cultures. J Lab Clin Med (1970) 1.03
The effect of bacterial products on synovial fibroblast function: hypermetabolic changes induced by endotoxin. J Clin Invest (1972) 1.02
Leukocyte-connective tissue cell interaction. II. The specificity, duration, and mechanism of interaction effects. Arthritis Rheum (1969) 1.02
Connective tissue activation. I. The nature, specificity, measurement and distribution of connective tissue activating peptide. Arthritis Rheum (1971) 1.00
Connective tissue activation. XXI. Regulation of glycosaminoglycan metabolism by lymphocyte (CTAP-I) and platelet (CTAP-III) growth factors. In Vitro (1981) 0.99
Immunochemical method for detection of albumin in human meconium. Arch Dis Child (1974) 0.95
Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor. J Leukoc Biol (1991) 0.94
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest (1990) 0.92
Connective tissue activation. VII. Evidence supporting a role for prostaglandins and cyclic nucleotides. J Lab Clin Med (1975) 0.91
An improved method for immobilizing IgG antibodies on protein A-agarose. J Immunol Methods (1990) 0.90
The excretion of nondialyzable urinary mucopolysaccharide in rheumatic and other systemic disease states. J Lab Clin Med (1966) 0.89
Connective tissue activation. XV. Stimulation of glycosaminoglycan and DNA synthesis by a polymorphonuclear leukocyte factor. Arthritis Rheum (1980) 0.88
Connective tissue activation. XX. Stimulation of prostaglandin secretion by mediators from lymphocytes (CTAP-I) and platelets (CTAP-III). Arthritis Rheum (1981) 0.88
Connective tissue activation. VI. The effects of cylic nucleotides on human synovial cells in vitro. J Lab Clin Med (1974) 0.87
Connective tissue activation. XXII. A platelet growth factor (connective tissue-activating peptide-III) in human growth hormone-deficient patients. J Clin Endocrinol Metab (1981) 0.87
Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat. Cancer Res (1983) 0.86
Connective tissue activation. XXIII. Increased plasma levels of a platelet growth factor (CTAP-III) in patients with rheumatic diseases. Clin Chim Acta (1981) 0.86
Connective tissue activation. XXV. Regulation of proteoglycan synthesis in human synovial cells. Arthritis Rheum (1983) 0.86
Regional distribution of acid mucopolysaccharides in the kidney. J Clin Invest (1968) 0.85
Connective tissue activation. XXVII. The behavior of skin fibroblasts from patients with scleroderma. Arthritis Rheum (1983) 0.85
Anabolic and catabolic responses of human articular cells to growth factors. J Rheumatol (1987) 0.85
Rheumatoid behavior in normal human synovial fibroblasts induced by extracts of Gram-negative bacteria. J Lab Clin Med (1975) 0.84
Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study. Cancer Treat Rep (1985) 0.84
Characteristics of normal and malignant human mesothelial cells studied in vitro. Lab Invest (1969) 0.84
Connective tissue activation XIX. Plasma levels of the CTAP-III platelet antigen in rheumatoid arthritis. J Rheumatol (1981) 0.84
Reaction after administration of macroaggregated albumin for a lung scan. N Engl J Med (1966) 0.83
Connective tissue activation. V. The flux of connective tissue activating peptide during acute inflammation. J Lab Clin Med (1973) 0.82
Connective tissue activation. X. Current studies of the process and its mediators. Scand J Rheumatol Suppl (1975) 0.82
Connective tissue activating peptides. Methods Enzymol (1988) 0.81
Connective tissue activation. XIII. Stimulation of sulfated glycosaminoglycan synthesis in human connective tissue cells by peptide mediators from lymphocytes and platelets. J Lab Clin Med (1978) 0.80
Acid mucopolysaccharide composition of serous effusions. Study of 100 patients with neoplastic and non-neoplastic conditions. Cancer (1967) 0.80
A mucopolysaccharidosis with increased urinary excretion of chondroitin-4 sulfate. Ann Intern Med (1971) 0.80
Preparation and bioassay of connective tissue activating peptide III and its isoforms. Methods Enzymol (1991) 0.80
Characteristics of an antigen reactivity in synovial fluids and its association with rheumatoid arthritis. Proc Soc Exp Biol Med (1977) 0.80
Leukocyte-connective tissue cell interaction. I. Stimulation of hyaluronate synthesis by live and dead leukocytes. Arthritis Rheum (1969) 0.79
Effect of gestational length on albumin content of meconium. Arch Dis Child (1976) 0.79
Connective tissue activating peptide III. Induction of synthesis and secretion of plasminogen activator by synovial fibroblasts. Arthritis Rheum (1984) 0.79
Connective tissue activation. XII. Platelet abnormalities in patients with rheumatoid arthritis. J Rheumatol (1978) 0.79
Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol (1992) 0.79
Regulation of glucose transporters by connective tissue activating peptide-III isoforms. J Biol Chem (1992) 0.78
The effect of heparin on the cytotoxicity and uptake of anti-neoplastic drugs in cultured Burkitt lymphoma cells. Cancer Res (1974) 0.78
Connective tissue activation: stimulation of glucose transport by connective tissue activating peptide III. Biochemistry (1985) 0.78
The effect of drug therapy on the uptake of radioactive fluorine by osseous metastases. Clin Pharmacol Ther (1967) 0.78
Activation of lung connective tissue cells in vitro. Am Rev Respir Dis (1979) 0.78
Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins. Ann Clin Lab Sci (1982) 0.77
Connective tissue activation. 3. Observations on the mechanism of action of connective tissue activating peptide. J Lab Clin Med (1972) 0.77
Connective tissue activation in guinea pig lung fibroblast cultures: regulatory effects of glucocorticoids. In Vitro (1981) 0.77
Connective tissue activation: VIII. The effects of temperature studied in vitro. Arch Phys Med Rehabil (1976) 0.77
Periarticular fibrosis associated with idiopathic retroperitoneal fibrosis. J Rheumatol (1988) 0.76
Sweat testing for cystic fibrosis. Arch Dis Child (1978) 0.75
Connective tissue activation. IV. Regulatory effects of antirheumatic drugs. Arthritis Rheum (1973) 0.75
Factors modifying DNA synthesis by lung fibroblasts in vitro. Proc Soc Exp Biol Med (1982) 0.75
Connective tissue activation. XXXII. Structural and biologic characteristics of mesenchymal cell-derived connective tissue activating peptide-V. Arthritis Rheum (1987) 0.75
Connective tissue activation. IX. Modification by pharmacologic agents. Arthritis Rheum (1976) 0.75
Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study. Cancer Treat Rep (1986) 0.75
Arthritis and Aerobic Exercise: A Review. Phys Sportsmed (1989) 0.75
Connective tissue activation. XXVIII. A connective tissue activating peptide from human urine. Arthritis Rheum (1984) 0.75
Connective tissue activation. XXXI. Identification of two molecular forms of a human mesenchymal cell-derived growth factor, connective tissue activating peptide-V. Arthritis Rheum (1987) 0.75
Preparation and characterization of antibodies with specificity for the amino-terminal tetrapeptide sequence of the platelet-derived connective tissue activating peptide-III. Biochem Int (1985) 0.75
Regulation of connective tissue metabolism by autacoid mediators. J Rheumatol Suppl (1983) 0.75
Pseudogout associated with meniscal cysts - report of two patients. J Rheumatol (1978) 0.75
Azathioprine treatment in Crohn's disease. Am J Gastroenterol (1974) 0.75
Hyaluronic acid and proteoglycan synthesis by lung fibroblasts in basal and activated states. In Vitro (1983) 0.75
Measurement of urinary and serous-fluid glycosaminoglycans and urinary hydroxyproline. Am J Clin Pathol (1977) 0.75
Connective tissue formation by lung fibroblasts in vitro. Am Rev Respir Dis (1979) 0.75
Growth factors in human disease: the realities, pitfalls, and promise. Semin Arthritis Rheum (1985) 0.75
Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3. Oncology (1975) 0.75
Effects of human carbonic anhydrase III (CA III) on synovial and muscle fibroblast glycosaminoglycan metabolism. Proc Soc Exp Biol Med (1987) 0.75
Uptake of cortisol by rheumatoid and nonrheumatoid fibroblasts in tissue culture. Lab Invest (1972) 0.75
Connective tissue activating peptide-V and CD59: a molecule in search of a job. J Rheumatol (1996) 0.75
A possible receptor-binding function for the N-terminus of connective tissue activating peptide III. Biochemistry (1990) 0.75
Bleomycin, vincristine, and mitomycin C with or without methotrexate in the treatment of squamous cell carcinoma. Cancer Treat Rep (1981) 0.75
Drug therapy for neoplastic disease in adults. Med Clin North Am (1969) 0.75
Connective tissue activation. XXX: Isoelectric point microheterogeneity of CTAP-III, a human platelet-derived growth factor. Proc Soc Exp Biol Med (1986) 0.75
A reaction following administration of macroaggregated albumin (maa) for a lung scan. Am J Roentgenol Radium Ther Nucl Med (1966) 0.75
Letter: Effect of antibiotics on sweat chloride levels in cystic fibrosis. J Pediatr (1974) 0.75
Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera. Clin Chim Acta (1980) 0.75
Angiography of the nephrogenic hepatic dysfunction syndrome. Radiology (1974) 0.75
Connective tissue activation in vitro: suppression by antirheumatic drugs. J Lab Clin Med (1971) 0.75
Connective tissue activation XXVI: IgG stimulation of glycosaminoglycan synthesis in human synovial cultures. J Rheumatol (1983) 0.75
Connective tissue activation. XVI. Detection of a human platelet-derived connective tissue activating peptide (CTAP-III) in human sera and plasma and in synovial fluids and tissues. Proc Soc Exp Biol Med (1980) 0.75